A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma

Int Rev Neurobiol. 2023:172:303-319. doi: 10.1016/bs.irn.2023.07.004. Epub 2023 Sep 19.

Abstract

Glioma is the most common primary central nervous tumor and its malignant and high recurrence rate are seriously threatening patient's life. The prognosis of glioma patients is still poor with a variety of modern treatments. Traditional Chinese medicine (TCM) is widely used in the adjuvant treatment or alternative medicine of glioma. Curcumae Rhizoma is one of the most commonly used in traditional Chinese medicine prescriptions for its anti-tumor characteristics. There are also many studies that reveals the anti-tumor effect of its active ingredients and some of which have been made into drugs and have been used in clinical practice. This review summarizes the new research progress on Curcumae Rhizoma for the treatment of glioma in recent years.

Keywords: Curcumae Rhizoma; Curcumin; Curcumol; Glioma; Traditional Chinese medicine; β-Elemene.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Curcuma
  • Drugs, Chinese Herbal* / therapeutic use
  • Glioma* / drug therapy
  • Humans
  • Medicine, Chinese Traditional
  • Rhizome

Substances

  • Drugs, Chinese Herbal